4 research outputs found
Multiscale Bone Remodelling with Spatial P Systems
Many biological phenomena are inherently multiscale, i.e. they are
characterized by interactions involving different spatial and temporal scales
simultaneously. Though several approaches have been proposed to provide
"multilayer" models, only Complex Automata, derived from Cellular Automata,
naturally embed spatial information and realize multiscaling with
well-established inter-scale integration schemas. Spatial P systems, a variant
of P systems in which a more geometric concept of space has been added, have
several characteristics in common with Cellular Automata. We propose such a
formalism as a basis to rephrase the Complex Automata multiscaling approach
and, in this perspective, provide a 2-scale Spatial P system describing bone
remodelling. The proposed model not only results to be highly faithful and
expressive in a multiscale scenario, but also highlights the need of a deep and
formal expressiveness study involving Complex Automata, Spatial P systems and
other promising multiscale approaches, such as our shape-based one already
resulted to be highly faithful.Comment: In Proceedings MeCBIC 2010, arXiv:1011.005
Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia
Schizophrenia is a debilitating psychiatric disease with a strong genetic contribution, potentially linked to altered glutamatergic function in brain regions such as the prefrontal cortex (PFC). Here, we report converging evidence to support a functional candidate gene for schizophrenia. In post-mortem PFC from patients with schizophrenia, we detected decreased expression of MKK7/MAP2K7—a kinase activated by glutamatergic activity. While mice lacking one copy of the Map2k7 gene were overtly normal in a variety of behavioural tests, these mice showed a schizophrenia-like cognitive phenotype of impaired working memory. Additional support for MAP2K7 as a candidate gene came from a genetic association study. A substantial effect size (odds ratios: ∼1.9) was observed for a common variant in a cohort of case and control samples collected in the Glasgow area and also in a replication cohort of samples of Northern European descent (most significant P-value:3 3 1024). While some caution is warranted until these association data are further replicated, these resultsare the first to implicate the candidate gene MAP2K7 in genetic risk for schizophrenia. Complete sequencing of all MAP2K7 exons did not reveal any non-synonymous mutations. However, the MAP2K7 haplotype appeared to have functional effects, in that it influenced the level of expression of MAP2K7 mRNA in humanPFC. Taken together, the results imply that reduced function of the MAP2K7-c-Jun N-terminal kinase (JNK) signalling cascade may underlie some of the neurochemical changes and core symptoms in schizophrenia